ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pediatrics

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,246Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 14

$765K Total Retail Price of All Prescriptions

Rank: 1 out of 14

620 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 620 patients filled at least one prescription for a schedule two drug, compared to an average of 16%.

Schedule Three
Controlled Substances

14% of this provider’s 620 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 11,044 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
OMEPRAZOLE 370 350 1 1
FUROSEMIDE 359 346 2 6
LEVOTHYROXINE SODIUM 348 319 3 5
LISINOPRIL 327 293 4 3
POLYETHYLENE GLYCOL 3350 262 251 5 13
SIMVASTATIN 258 239 6 2
AMLODIPINE BESYLATE 242 236 7 4
METOPROLOL TARTRATE 235 222 8 11
CITALOPRAM HBR 214 199 9 16
HYDROCODONE-ACETAMINOPHEN 200 187 S3 10 8
JANTOVEN 187 187 11 30
LOSARTAN POTASSIUM 184 183 12 32
ATENOLOL 177 165 13 15
ATORVASTATIN CALCIUM 167 157 14 14
METFORMIN HCL 166 156 15 10
FLUTICASONE PROPIONATE 163 137 16 35
SPIRIVA 162 126 17 23
GABAPENTIN 137 118 18 18
ALENDRONATE SODIUM 131 130 19 42
DONEPEZIL HCL 126 126 20 44
LOVASTATIN 124 112 21 45
MIRTAZAPINE 124 111 21 45
ALBUTEROL SULFATE 121 121 23 47
HYDROCHLOROTHIAZIDE 115 106 24 31
MELOXICAM 114 109 25 34
TAMSULOSIN HCL 114 89 25 33
KLOR-CON M10 107 105 27 50
IPRATROPIUM BROMIDE 103 103 28 51
PRAVASTATIN SODIUM 101 84 29 25
DIOVAN 98 98 30 21
WARFARIN SODIUM 96 89 31 54
CYMBALTA 91 86 32 55
KLOR-CON M20 91 79 32 55
CLOPIDOGREL 91 88 32 55
TRAZODONE HCL 89 84 35 58
SERTRALINE HCL 88 81 36 40
JANUVIA 88 74 36 59
BYSTOLIC 88 85 36 59
PAROXETINE HCL 87 73 39 61
ZOLPIDEM TARTRATE 84 72 40 39
NAMENDA 76 73 41 64
PLAVIX 76 74 41 37
SYMBICORT 74 70 43 65
NEXIUM 73 57 44 22
FAMOTIDINE 69 69 45 67
TRAMADOL HCL 68 60 46 27
HALOPERIDOL 68 68 46 68
DIGOXIN 66 65 48 72
CARVEDILOL 66 66 48 72
PROAIR HFA 63 56 50 74
PATADAY 63 63 50 74
RAMIPRIL 61 55 52 78
ISOSORBIDE MONONITRATE ER 58 44 53 81
NYSTATIN 57 51 54 82
MEGESTROL ACETATE 56 56 R 55 83
POTASSIUM CHLORIDE 56 49 55 12
VENTOLIN HFA 56 40 55 83
ADVAIR DISKUS 55 52 58 86
RANITIDINE HCL 55 52 58 7
ENALAPRIL MALEATE 54 35 60 88
LANTUS 53 41 61 43
METHYLPREDNISOLONE 53 45 61 91
GLIMEPIRIDE 52 37 63 41
CARBIDOPA-LEVODOPA 50 50 64 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.